244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells

The epidermal growth factor receptor (EGFR) is known to play a critical role in non-small cell lung cancer(NSCLC). Several EGFR tyrosine kinase inhibitors(TKIs), such as gefitinib, have been used as effective clinical therapies for patients with NSCLC. Unfortunately, acquired resistance to gefitinib...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncotarget
मुख्य लेखकों: Zhang, Yi, Yao, Ke, Shi, Chengcheng, Jiang, Yanan, Liu, Kangdong, Zhao, Song, Chen, Hanyong, Reddy, Kanamata, Zhang, Chengjuan, Chang, Xiaoyu, Ryu, Joohyun, Bode, Ann M., Dong, Ziming, Dong, Zigang
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Impact Journals LLC 2015
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792556/
https://ncbi.nlm.nih.gov/pubmed/26517520
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन